Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


 Company News
Hemispherx Biopharma (HEB) Reports on Annual Stockholder Meeting 11/17/2014 2:13:11 PM
Hemispherx Biopharma (HEB) Release: Ampligen(R) Blocks Critical Ebola Viral Disease (EVD) Protein Which Is Linked To High Mortality In Man 11/17/2014 12:28:03 PM
Hemispherx Biopharma (HEB) Announces Financial Results For The Nine Months Ended September 30, 2014 11/10/2014 7:49:06 AM
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Collaborate On Alferon® And Ampligen® Against The Ebola Virus 11/3/2014 7:26:09 AM
Hemispherx Biopharma (HEB) Reports New Evidence -- Based Potential Of Ampligen® Against Ebola Virus Disease (EVD) 10/30/2014 7:59:17 AM
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014 1:47:45 PM
Hemispherx Biopharma (HEB) Prevails In Multi-Million Dollar Federal Lawsuit 10/20/2014 7:24:38 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Hemispherx Biopharma (HEB) Director Dr. William Mitchell To Present Research On Treating Deadly Emerging Viruses During The 4th World Congress On Virology October 8 10/7/2014 7:52:29 AM
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014 8:05:44 AM